Statin dose equivalence
Pro Research Analysisby 
Searched over 200M research papers
Statin Dose Equivalence: Comparative Potency and Lipid-Lowering Effects
Statin Dose Equivalence and LDL Cholesterol Reduction
Research shows that all statins lower LDL cholesterol, but their potency varies by type and dose. Atorvastatin, rosuvastatin, and simvastatin are broadly equivalent in their LDL cholesterol-lowering effects at higher doses: atorvastatin >40 mg/day, rosuvastatin >10 mg/day, and simvastatin >40 mg/day achieve similar reductions in LDL and total cholesterol. Lower doses of fluvastatin (≤20 mg/day) and lovastatin (≤10 mg/day) are less effective at reducing LDL cholesterol compared to other statins at standard doses.
Statin Dose Conversion: Milligram Equivalents
Guidelines and comparative studies provide practical dose equivalence:
- Pravastatin 10 mg ≈ Simvastatin 10 mg
- Atorvastatin 10 mg ≈ Simvastatin 20 mg
- Rosuvastatin 10 mg ≈ Atorvastatin 30 mg ≈ Simvastatin 60 mg
However, the maximum recommended doses for simvastatin (80 mg/day) and rosuvastatin (40 mg/day) mean that very high LDL reductions may not be achievable with simvastatin alone, especially when compared to high-dose atorvastatin or rosuvastatin.
Dose-Response Relationship and Clinical Outcomes
Higher statin doses generally lead to greater reductions in LDL cholesterol, but the clinical benefit of doubling the dose may be limited, especially in populations with already low baseline LDL levels. For example, in patients with acute coronary syndrome and low baseline LDL, doubling the statin dose (e.g., atorvastatin 20–40 mg vs. 10 mg) resulted in only a modest additional LDL reduction and did not significantly improve clinical outcomes over two years.
Statin Dose and Safety Considerations
When comparing statins at equivalent lipid-lowering doses, the risk of muscular side effects does not differ significantly between hydrophilic (e.g., pravastatin, rosuvastatin) and lipophilic (e.g., simvastatin, atorvastatin) statins. Additionally, increasing statin dose may reduce periprocedural complications in certain settings, such as carotid artery stenting, in a dose-dependent manner. However, in other contexts, such as preoperative use before cardiac surgery, neither high nor low statin doses significantly affected short-term mortality or complications.
Practical Implications for Statin Dosing
- Atorvastatin, rosuvastatin, and simvastatin at higher doses are roughly equivalent in LDL-lowering potency.
- Dose conversions are important for switching between statins, but maximum recommended doses must be respected.
- Doubling the statin dose provides diminishing returns in LDL reduction and may not always translate to better clinical outcomes, especially in patients with low baseline LDL.
- Safety profiles are similar across statins at equivalent doses, and the choice of statin may depend on patient-specific factors and tolerability.
Conclusion
Statin dose equivalence is well established for major statins, with atorvastatin, rosuvastatin, and simvastatin showing similar LDL-lowering effects at higher doses. Dose conversions help guide therapy adjustments, but clinical benefits of higher doses may be limited in some populations. Safety profiles are comparable across statins at equivalent doses, supporting individualized statin selection and dosing based on patient needs and treatment goals1245+2 MORE.
Sources and full results
Most relevant research papers on this topic